Iterum Therapeutics PLC (ITRM) — Financial Flexibility Index
Iterum Therapeutics PLC (ITRM) has a Financial Flexibility Index of -0.20x as of September 2025. Free cash flow of $-7.84 Million (operating CF $-7.85 Million minus capex $12.57K) represents 0% of total liabilities ($39.88 Million). Check asset allocation strategy of Iterum Therapeutics PLC to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Iterum Therapeutics PLC Financial Flexibility Index (2016–2024)
Historical Financial Flexibility Index trend for Iterum Therapeutics PLC across 9 annual periods. See ITRM working capital efficiency to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Iterum Therapeutics PLC (2016–2024)
Year-by-year free cash flow to debt coverage for Iterum Therapeutics PLC. For the full company profile including market capitalisation, see market value of Iterum Therapeutics PLC.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.55x | $-26.77 Million | $-26.77 Million | $48.68 Million | ▲ +54.3% |
| 2023 | -1.20x | $-39.32 Million | $-39.33 Million | $32.66 Million | ▼ -153.9% |
| 2022 | -0.47x | $-18.41 Million | $-18.47 Million | $38.83 Million | ▼ -24.0% |
| 2021 | -0.38x | $-15.78 Million | $-15.84 Million | $41.27 Million | ▲ +41.5% |
| 2020 | -0.65x | $-54.52 Million | $-54.53 Million | $83.35 Million | ▲ +58.5% |
| 2019 | -1.58x | $-81.90 Million | $-81.92 Million | $51.99 Million | ▲ +45.4% |
| 2018 | -2.89x | $-75.80 Million | $-75.89 Million | $26.25 Million | ▲ +29.6% |
| 2017 | -4.10x | $-29.79 Million | $-30.60 Million | $7.26 Million | ▼ -66.2% |
| 2016 | -2.47x | $-10.49 Million | $-11.30 Million | $4.25 Million | — |